Literature DB >> 32340594

Effectiveness of Suicide-Focused Psychosocial Interventions in Psychosis: A Systematic Review and Meta-Analysis.

Lindsay A Bornheimer1, Anao Zhang1, Juliann Li1, Matthew Hiller1, Nicholas Tarrier1.   

Abstract

OBJECTIVE: Suicide ideation, plan, attempt, and death are significant and prevalent concerns among individuals with psychosis. Previous studies have focused on risk factors, but few have systematically evaluated the effect of psychosocial interventions on these experiences among individuals with psychosis. This study evaluated the effectiveness of psychosocial interventions in reducing suicide ideation, plan, attempt, and death among individuals with psychotic symptoms.
METHODS: Eight electronic databases were systematically searched from inception until June 30, 2019. Identified studies included both randomized controlled trials and controlled trials without randomization that examined psychosocial interventions for suicide ideation, plan, attempt, and death among individuals with psychotic symptoms. A random-effects model was used to pool the effect sizes for synthesis.
RESULTS: Eleven studies with 14 effect sizes (N=4,829 participants) were analyzed. The average age of participants ranged from 21 to 51, and most participants identified as male and non-Hispanic Caucasian or Chinese and were in an early or first-episode stage of illness. On average, participants who received psychosocial interventions were less likely than their counterparts in the control group to report suicide ideation, plan, and attempt and die by suicide (odds ratio [OR]=0.57, 95% confidence interval [CI]=0.41-0.78). Subgroup analyses further revealed significant reductions in suicide ideation (OR=0.73, 95% CI=0.55-0.97) and suicide death (OR=0.45, 95% CI=0.30-0.68) among intervention participants.
CONCLUSIONS: Preliminary evidence indicated that psychosocial interventions are effective in reducing suicide ideation, plan, attempt, and death among individuals with psychotic symptoms. Intervention characteristics, however, varied across studies, which suggests a lack of consensus on best clinical practices.

Entities:  

Keywords:  Schizophrenia; Suicide and self-destructive behavior

Mesh:

Year:  2020        PMID: 32340594     DOI: 10.1176/appi.ps.201900487

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  6 in total

1.  Modifying a cognitive behavioral suicide prevention treatment for adults with schizophrenia spectrum disorders in community mental health.

Authors:  Lindsay A Bornheimer; Juliann Li Verdugo; Joshua Holzworth; Vitalis Im; Fonda N Smith; Hannah Sliwa; Stephan F Taylor; Cheryl A King; Timothy Florence; Nicholas Tarrier; Joseph A Himle
Journal:  Psychiatry Res       Date:  2022-03-07       Impact factor: 11.225

2.  Continuity of care and mortality in people with schizophrenia.

Authors:  Alastair Macdonald; Dimitrios Adamis; Matthew Broadbent; Tom Craig; Rob Stewart; Robin M Murray
Journal:  BJPsych Open       Date:  2021-07-09

3.  Mental health provider perspectives of the COVID-19 pandemic impact on service delivery: a focus on challenges in remote engagement, suicide risk assessment, and treatment of psychosis.

Authors:  Lindsay A Bornheimer; Juliann Li Verdugo; Joshua Holzworth; Fonda N Smith; Joseph A Himle
Journal:  BMC Health Serv Res       Date:  2022-05-31       Impact factor: 2.908

4.  Psychosocial interventions for self-harm in adults.

Authors:  Katrina G Witt; Sarah E Hetrick; Gowri Rajaram; Philip Hazell; Tatiana L Taylor Salisbury; Ellen Townsend; Keith Hawton
Journal:  Cochrane Database Syst Rev       Date:  2021-04-22

5.  Suicidal ideation in first-episode psychosis: Considerations for depression, positive symptoms, clinical insight, and cognition.

Authors:  Lindsay A Bornheimer; Jessica A Wojtalik; Juliann Li; Derin Cobia; Matthew J Smith
Journal:  Schizophr Res       Date:  2021-01-23       Impact factor: 4.939

Review 6.  [Psychotherapy after a suicide attempt-current evidence and evaluation].

Authors:  Tobias Teismann; Anja Gysin-Maillart
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2021-12-08       Impact factor: 1.513

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.